Luis Hernández
Grup de recerca
- Patologia molecular en neoplàsies limfoides Accredited researcher (R3A)
Publicacions destacades
-
Expression of the transcribed ultraconserved region 70 and the related long non-coding RNA AC092652.2-202 has prognostic value in Chronic Lymphocytic Leukaemia.
Autors:Referència: British Journal Of Haematology 2019. -
Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas
Autors:Referència: British Journal Of Haematology 2019. -
SOXC And MiR17-92 Gene Expression Profiling Defines Two Subgroups With Different Clinical Outcome In Mantle Cell Lymphoma
Autors:Referència: Genes Chromosomes & Cancer 2016. -
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
Autors:Referència: Oncotarget 2015. -
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Autors:Referència: Proceedings Of The National Academy Of Sciences Of The United States Of America 2013. -
microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics
Autors:Referència: Clinical Cancer Research 2013. -
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Autors:Referència: Nature Genetics 2012. -
MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas
Autors:Referència: Cancer Research 2009. -
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Autors:Referència: American Journal Of Pathology 2009.
Projectes destacats
-
Cross border network of personalized immunotherapies in non-Hodgkin lymphoma.
Investigador/a principal: Patricia Pérez GalánFinançador: EU-INTERRREG-POCTEFA (Programa financiador competitivo)Codi: EFA281/16/IMLINFODurada: 01/01/2018 - 31/12/2020 -
Búsqueda de IncRNAs relacionados con la polarización de macrófagos pro-tumorogénicos (M2-TAM) en linfomas foliculares/ difusos de células grandes y evaluación de su valor clínico
Investigador/a principal: Luis Hernández PousFinançador: Instituto de Salud Carlos IIICodi: PI15/00551Durada: 01/01/2016 - 31/12/2018 -
CIBER de Cáncer
Investigador/a principal: Elías Campo GüerriFinançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Codi: CB16/12/00225Durada: 01/01/2017 - 31/12/2023 -
BÚSQUEDA DE lncRNAS COMO BIOMARCADORES RELEVANTES EN LAS CÉLULAS TUMORALES Y DEL MICROAMBIENTE DE LOS LINFOMAS FOLICULARES
Investigador/a principal: Hernandez LFinançador: Instituto de Salud Carlos III (ISCIII) ; IDIBAPS (Participante)Codi: PI12/01302Durada: 01/01/2013 - 31/12/2015 -
PATTERNS OF MICRORNA EXPRESSION AND THEIR MODULATION BY B CELL RECEPTOR MEDIATED STIMULI IN IGM-EXPRESSING LYMPHOPROLIFERATIVE DISORDERS: IMPLICATIONS FOR THERAPY
Finançador: Centro di Referimento Oncologico (CRO) ; IDIBAPS (Participante)Codi: Intramural Grant 2011-12: bench to bedside proposalsDurada: 01/01/2013 - 31/12/2014